MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 61 filers reported holding MARKER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,731 | -45.4% | 10,273 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | -50.0% | 10,273 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $10,000 | -41.2% | 10,273 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $17,000 | -41.4% | 10,273 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $29,000 | +26.1% | 10,273 | 0.0% | 0.01% | +20.0% |
| Q1 2021 | $23,000 | +53.3% | 10,273 | 0.0% | 0.01% | +66.7% |
| Q4 2020 | $15,000 | 0.0% | 10,273 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $15,000 | -28.6% | 10,273 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $21,000 | +5.0% | 10,273 | 0.0% | 0.01% | -14.3% |
| Q1 2020 | $20,000 | -33.3% | 10,273 | 0.0% | 0.01% | -22.2% |
| Q4 2019 | $30,000 | -42.3% | 10,273 | 0.0% | 0.01% | -43.8% |
| Q3 2019 | $52,000 | -35.8% | 10,273 | 0.0% | 0.02% | -36.0% |
| Q2 2019 | $81,000 | +19.1% | 10,273 | 0.0% | 0.02% | +13.6% |
| Q1 2019 | $68,000 | +19.3% | 10,273 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $57,000 | – | 10,273 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,142,857 | $2,986,000 | 1.05% |
| ACT CAPITAL MANAGEMENT, LLC | 354,400 | $337,000 | 0.24% |
| NEA Management Company, LLC | 10,714,285 | $10,179,000 | 0.21% |
| Long Focus Capital Management, LLC | 1,233,257 | $1,172,000 | 0.16% |
| Mandatum Life Insurance Co Ltd | 99,000 | $94,000 | 0.02% |
| MATRIX ASSET ADVISORS INC/NY | 150,000 | $143,000 | 0.02% |
| AR ASSET MANAGEMENT INC | 71,500 | $68,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 590,118 | $561,000 | 0.01% |
| WealthTrust Axiom LLC | 22,700 | $21,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 324,216 | $308,000 | 0.01% |